csirt@kutim:~/threat-intel/cve/CVE-2023-29268

Katalog CVE

CVSS 9.8 · Critical EPSS 1,0%

Kerentanan Unrestricted Upload of File with Dangerous Type pada tibco spotfire statistics services. Skor CVSS 3.1 9.8 (Critical) menurut NVD.

Deskripsi (NVD)

The Splus Server component of TIBCO Software Inc.'s TIBCO Spotfire Statistics Services contains a vulnerability that allows an unauthenticated remote attacker to upload or modify arbitrary files within the web server directory on the affected system. Affected releases are TIBCO Software Inc.'s TIBCO Spotfire Statistics Services: versions 11.4.10 and below, versions 11.5.0, 11.6.0, 11.6.1, 11.6.2, 11.7.0, 11.8.0, 11.8.1, 12.0.0, 12.0.1, and 12.0.2, versions 12.1.0 and 12.2.0.

Rincian

Terbit di NVD
26 April 2023
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
9.8 (Critical), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-434: Unrestricted Upload of File with Dangerous Type
EPSS (30 hari)
1,0% peluang dieksploitasi; lebih tinggi dari 62,8% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
tibco spotfire statistics services Semua versi sebelum 11.4.11
tibco spotfire statistics services Versi 11.5.0
tibco spotfire statistics services Versi 11.6.0
tibco spotfire statistics services Versi 11.6.1
tibco spotfire statistics services Versi 11.6.2
tibco spotfire statistics services Versi 11.7.0
tibco spotfire statistics services Versi 11.8.0
tibco spotfire statistics services Versi 11.8.1
tibco spotfire statistics services Versi 12.0.0
tibco spotfire statistics services Versi 12.0.1
tibco spotfire statistics services Versi 12.0.2
tibco spotfire statistics services Versi 12.1.0
tibco spotfire statistics services Versi 12.2.0

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.